CTLA4 and myocarditis: Abatacept is an agonist of CTLA-4 that alleviates nivolumab-induced myocarditis in lung cancer treatment (Salem et al., 2019) as well as pembrolizumab-induced myocarditis in melanoma treatment (Liu et al., 2020).